Lazertinib
N-[5-[[4-[4-[(dimethylamino)methyl]-3-phenylpyrazol-1-yl]pyrimidin-2-yl]amino]-4-methoxy-2-morpholin-4-ylphenyl]prop-2-enamide
Molecular Identity
Lazertinib
N-[5-[[4-[4-[(dimethylamino)methyl]-3-phenylpyrazol-1-yl]pyrimidin-2-yl]amino]-4-methoxy-2-morpholin-4-ylphenyl]prop-2-enamide
PubChem CID: 121269225
2D Structure
Properties
C30H34N8O3
Molecular Formula
554.60
Molecular Weight
g/mol
554.2754
Exact Mass
Da
3.4
XLogP
Drug-like (Lipinski: < 5)
110
TPSA
Good oral absorption (< 140 A²)
2
H-Bond Donors
9
H-Bond Acceptors
837
Complexity
SMILES
Canonical SMILES
SMILES: Synonyms(20)
Lazertinib1903008-80-9YH-25448YH25448GNS1480GNS-1480JNJ-73841937-AAAN-(5-((4-(4-((Dimethylamino)methyl)-3-phenyl-1H-pyrazol-1-yl)pyrimidin-2-yl)amino)-4-methoxy-2-morpholinophenyl)acrylamideC-18112003-GLazcluze4A2Y23XK11N-[5-[[4-[4-[(dimethylamino)methyl]-3-phenylpyrazol-1-yl]pyrimidin-2-yl]amino]-4-methoxy-2-morpholin-4-ylphenyl]prop-2-enamide2-Propenamide, N-(5-((4-(4-((dimethylamino)methyl)-3-phenyl-1H-pyrazol-1-yl)-2-pyrimidinyl)amino)-4-methoxy-2-(4-morpholinyl)phenyl)-lazertinibumN-(5-((4-(4-((dimethylamino)methyl)-3-phenylpyrazol-1-yl)pyrimidin-2-yl)amino)-4-methoxy-2-morpholin-4-ylphenyl)prop-2-enamide
Data from PubChem (NCBI)
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.
Drug Network
Trials and conditions connected to Lazertinib
Loading drug network...